Kamel, Kerollos
Yu, Amy J.
Choi, Alison Y.
Sadeghi, Elham
Chhablani, Jay https://orcid.org/0000-0003-1772-3558
Article History
Received: 16 June 2025
Revised: 3 November 2025
Accepted: 18 November 2025
First Online: 29 November 2025
Competing interests
: JC has the following financial disclosures: Owner (NetraMind Innovations); Consultant/Contractor (Salutaris, Allergan, Novartis, Erasca, OD-OS, B&L, Iveric Bio); Equity (Ocular therapeutics, AcuViz, Abbvie); Royalty (Springer, Elsevier). All other authors have no financial disclosures.